What is the recommended dosing for adenosine (adenosine) in the treatment of supraventricular tachycardia (SVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adenosine Dosing for Supraventricular Tachycardia

For acute treatment of SVT, administer adenosine 6 mg as a rapid IV bolus over 1-2 seconds through a proximal vein, followed immediately by a 20 mL saline flush; if unsuccessful after 1-2 minutes, give 12 mg rapid IV bolus, which may be repeated once more for a maximum total dose of 30 mg. 1, 2

Initial Dosing Protocol

  • Start with 6 mg IV push administered over 1-2 seconds, not 12 mg, as the initial dose successfully converts 70-80% of PSVT cases involving AVNRT or AVRT 2, 3
  • Use the most proximal IV access available (antecubital or higher) to ensure rapid delivery to central circulation before the drug is metabolized 2, 4
  • Follow immediately with a rapid 20 mL saline flush to propel the medication into central circulation 2, 4
  • Administer as a true rapid bolus over 1-2 seconds, not a slow push—this is critical for efficacy 2

Subsequent Dosing if Initial Dose Fails

  • If no conversion occurs within 1-2 minutes, administer 12 mg rapid IV bolus using the same technique 1, 2
  • The 12 mg dose may be repeated once more if still no response after another 1-2 minutes 1, 2
  • Maximum total cumulative dose is 30 mg (6 mg + 12 mg + 12 mg), though some guidelines cite 24 mg as the safe maximum 1, 2, 3
  • Overall conversion rates with this protocol range from 78% to 96% for AVNRT or AVRT 2, 3

Modified Dosing for Special Populations

Reduce initial dose to 3 mg in the following situations: 2, 4

  • Patients taking dipyridamole (potentiates adenosine effect)
  • Patients taking carbamazepine (increases risk of heart block)
  • Cardiac transplant recipients (denervated hearts are hypersensitive)
  • Administration via central venous access (drug reaches heart faster with less degradation) 5

Increase doses may be required for patients with significant blood levels of: 2, 4

  • Theophylline
  • Caffeine
  • Theobromine (methylxanthines competitively antagonize adenosine receptors)

Administration Technique Critical Points

  • Maintain continuous ECG monitoring during administration to document conversion or aid diagnostic evaluation 2
  • Have a defibrillator immediately available, particularly when Wolff-Parkinson-White syndrome is a consideration, as adenosine can precipitate atrial fibrillation with rapid ventricular rates 4
  • Position the patient supine if possible, as transient hypotension may occur 1

Expected Adverse Effects (Usually Transient, <60 seconds)

  • Flushing, chest discomfort/pain, and dyspnea are the most common side effects 1, 3
  • Transient AV block (expected therapeutic effect) 1
  • Rare but important: bronchospasm, complete heart block, initiation of atrial fibrillation (occurs in 1-15% of cases) 3
  • All adverse effects typically resolve within 60 seconds due to adenosine's half-life of less than 10 seconds 1, 6

Absolute Contraindications

  • Second- or third-degree AV block without a functioning pacemaker 1, 7
  • Sinus node disease (sick sinus syndrome, symptomatic bradycardia) without a functioning pacemaker 1, 7
  • Severe asthma or active bronchospasm (adenosine can precipitate life-threatening bronchospasm) 2, 3, 4, 7
  • Known hypersensitivity to adenosine 7

Use With Extreme Caution

  • Pre-excited atrial fibrillation or flutter (can cause accelerated ventricular response) 1, 3
  • Wolff-Parkinson-White syndrome with atrial fibrillation 4

Pregnancy Considerations

  • Adenosine is safe and effective during pregnancy 1, 4
  • Use the standard dosing protocol: 6 mg initial dose, followed by up to two 12 mg doses if needed 1
  • Adverse effects to the fetus are not expected given adenosine's extremely short half-life prevents it from reaching fetal circulation 1
  • Maternal side effects (chest discomfort, flushing) are transient 1

If Adenosine Fails

  • For hemodynamically stable patients, consider longer-acting AV nodal blocking agents such as IV diltiazem or metoprolol 2, 3, 4
  • For hemodynamically unstable patients, proceed immediately to synchronized cardioversion 2, 3
  • Adenosine may unmask atrial flutter or atrial tachycardia by transiently slowing AV conduction, even when it doesn't terminate the arrhythmia—this diagnostic information guides subsequent therapy 2, 3

Common Pitfalls to Avoid

  • Do not use slow IV push—adenosine must be given as a rapid 1-2 second bolus or it will be metabolized before reaching the heart 2
  • Do not forget the saline flush—without immediate flush, the drug may not reach central circulation in time 2, 4
  • Do not use distal IV sites—peripheral hand or wrist IVs significantly reduce efficacy 2, 4
  • Do not start with 12 mg—the 6 mg dose converts 70-80% of cases with fewer side effects 2, 3
  • Do not give to asthmatics—this is an absolute contraindication due to risk of severe bronchospasm 4, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adenosine Dosing for Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adenosine Dosing for Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adenosine Administration for Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.